A phase I study of cancer vaccine with CHP-MAGE-A4 in patients with advanced cancers expressing MAGE-A4 antigen
Phase of Trial: Phase I
Latest Information Update: 13 May 2016
At a glance
- Drugs CHP-MAGE-A4 (Primary)
- Indications Colon cancer; Gastric cancer; Non-small cell lung cancer; Oesophageal cancer
- Focus Adverse reactions; Therapeutic Use
- 13 Nov 2015 Linked profile to RDI: 43713
- 15 Aug 2012 Planned end date (Dec 2012) added as reported by University Hospital Medical Information Network - Japan.
- 15 Aug 2012 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.